Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diurnal Group Plc (DNL.LN)

Diurnal Group Plc (DNL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diurnal Group Plc Cardiff Medicentre Heath Park Cardiff CF14 4UJ GBR

https://www.diurnal.co.uk P: 292-068-2069

Description:

Diurnal Group PLC is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism, and Hypothyroidism. The company has two products in late-stage clinical development targeting Adrenal diseases; Chronocort to be used for the treatment of Congenital Adrenal Hyperplasia and Adrenal Insufficiency in Adults and Infacort which is to be used for the same conditions in children. Its main country of operation is the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 47,737
Shares Outstanding, K 169,720
Annual Sales, $ 4,684 K
Annual Net Income, $ -16,570 K
% of Insider Shareholders 2.57%
% of Institutional Shareholders 16.64%

Growth:

1-Year Return -54.65%
3-Year Return -13.33%
5-Year Return -80.84%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.10
Dividend Payout Ratio 0.00%

DNL.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -56.08%
Return-on-Assets % -48.46%
Profit Margin % -353.76%
Debt/Equity N/A
Price/Sales 9.86
Price/Book 2.22
Book Value/Share 0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar